IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Johnson & Johnson Innovation - Jjdc, Inc.

Q4 2020 Holdings

Filed 2021-02-09 | 15 holdings | $254.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals(ARWR)COM04280A100$250.2M3,260,86998.2%
Aldeyra Therapeutics, Inc.(ALDX)COM01438T106$4.1M594,8341.6%
Fate Therapeutics, Inc.(FATE)COM31189P102$307.3K3,379,0640.1%
Protagonist Therapeutics Inc.(PTGX)COM74366E102$49.4K2,449,1830.0%
Legend Biotech Corporation(LEGN)SPONSORED ADS52490G102$45.9K1,629,1730.0%
MeiraGTx Holdings plc(MGTX)COMG59665102$43.9K2,898,5500.0%
Fusion Pharmaceuticals Inc.COM36118A100$43.1K3,670,5160.0%
BiomX Inc.COM09090D103$13.6K2,133,4020.0%
Adicet Bio, Inc.(TORCEUR)COM007002108$9.3K662,6760.0%
PhaseBio Pharmaceuticals, Inc.COM717224109$5.4K1,607,0440.0%
Castlight Health Inc.(CSLT1EUR)CL B14862Q100$1.1K811,2950.0%
Tracon Pharmaceuticals, Inc.COM89237H209$98384,0030.0%
Senseonics Holdings, Inc.(SENS1GBP)COM81727U105$458525,6320.0%
Catalyst Biosciences, Inc.COM14888D208$42266,9510.0%
Pulmonx Corp(LUNG)COM745848101$3895,6390.0%